CAPASTAT

This brand name is authorized in Estonia, Spain, United States, South Africa

Active ingredients

The drug CAPASTAT contains one active pharmaceutical ingredient (API):

1 Capreomycin
UNII 9H8D3J7V21 - CAPREOMYCIN SULFATE

Capreomycin is active against human strains of Mycobacterium tuberculosis.

Read about Capreomycin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
J04AB30 Capreomycin J Antiinfectives for systemic use → J04 Antimycobacterials → J04A Drugs for treatment of tuberculosis → J04AB Antibiotics
Discover more medicines within J04AB30

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1131107, 1584817
Country: ES Centro de informaciรณn online de medicamentos de la AEMPS Identifier(s): 45261
Country: US FDA, National Drug Code Identifier(s): 17478-080
Country: ZA Health Products Regulatory Authority Identifier(s): A40/20.2.3/0680

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.